E-drug: Re: Withdrawal of ADEXOLIN in India
----------------------------------------------------------
Dear E-Druggers
I am happy and over-whelmed with the response recieved from around the
globe regarding my posting relating to the withdrawal of the Vit; A and
D preparation "Adexolin" from the market by the Glaxo Laboratories in
India. I have not made any formal complaints to the Glaxo management so
far. In our country Nutritional Blindness due to vit.A and ricketts due
vit.D are common public health problems in young children and we have a
National Health Program for control of Nutritional Blindness by
supplementing mega doses of Vit.A to our pre-school children
particularly in the rural areas. In this context, Withdrawal of Adexolin
from the market is unwarranted and against humanitarian values. Our
PHC's are struggling to maintain the regular supply of vit.A. Hope the
concerned authorities will look into this matter and come out with an
answer.
Hope the Glaxo laboratories in India will reconsider their stance
and Re-introduce Adexolin in the market
Dr.S.Gopalakrishnan
drsgopal@md3.vsnl.net.in
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.